Home › Funds › 1607 Capital Partners, LLC › BME

1607 Capital Partners, LLC position in BME

BLACKROCK HEALTH SCIENCES TR COM · Financials

1607 Capital Partners, LLC reported holding 163,553 shares of BME (BLACKROCK HEALTH SCIENCES TR COM) in its Q2 2026 13F filing — a position valued at US$7.0M, representing 0.61% of its reported portfolio and ranking #42 among its reported holdings. 1607 Capital Partners, LLC has disclosed BME holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)163.55K sh
Reported value held$7.02M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How 1607 Capital Partners, LLC's BME position evolved

1607 Capital Partners, LLC first disclosed a stake in BME in Q3 2023 at 88,092 shares (US$3.4M). The position peaked in Q3 2024 at 265,314 shares, worth US$11.1M. Across 12 filings, 1607 Capital Partners, LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 163,553 shares valued at US$7.0M — a reduction of -69,707 shares quarter over quarter.. Notable position changes include a 95% increase in Q4 2023 (shares rose 2% over the following quarter), a 84% increase in Q2 2024 (shares rose 3% over the following quarter), a 50% increase in Q4 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 88.09K $3.45M New
Q4 2023 171.74K $6.95M Add
Q1 2024 123.48K $5.12M Reduce
Q2 2024 227.79K $9.31M Add
Q3 2024 265.31K $11.12M Add
Q4 2024 176.01K $6.68M Reduce
Q1 2025 141.11K $5.45M Reduce
Q2 2025 153.50K $5.60M Add
Q3 2025 153.30K $5.71M Hold
Q4 2025 229.26K $9.43M Add
Q1 2026 233.26K $8.98M Add
Q2 2026 163.55K $7.02M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BME and 13F data

BME (BLACKROCK HEALTH SCIENCES TR COM) is a Financials company. 23 other funds we track also report a position in BME — the largest reported positions include Nova R Wealth, Inc. (US$6.1M), Cypress Capital Management LLC (WY) (US$2.3M), Alessandra Capital Management, LLC (US$897K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BME

All BME fund holders →

FAQ

How long has 1607 Capital Partners, LLC held BME?

1607 Capital Partners, LLC has disclosed BME holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is 1607 Capital Partners, LLC's current position in BME?

As of Q2 2026, 1607 Capital Partners, LLC holds 163.55K shares of BME (BLACKROCK HEALTH SCIENCES TR COM), valued at $7.02M, representing 0.61% of its reported portfolio and ranking #42.

Has 1607 Capital Partners, LLC been buying or selling BME?

In the latest 13F filing (Q2 2026), 1607 Capital Partners, LLC reduced its position in BME. The position peaked in Q3 2024 at 265.31K shares.

Which other funds hold BME?

Other major institutional holders of BME include Nova R Wealth, Inc., Cypress Capital Management LLC (WY), Alessandra Capital Management, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.